IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

Similar documents
Clinical characteristics

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Malignant Melanoma Early Stage. A guide for patients

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Periocular Malignancies

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

VACAVILLE DERMATOLOGY

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Dermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH

Living Beyond Cancer Skin Cancer Detection and Prevention

Identifying Benign and Malignant Skin Lesions. No Disclosures. Common Benign Lesions. Benign Lesions 2/25/2018. Stucco Keratoses.

Talking to Your Clients About Skin Cancer. Objectives 9/9/2017. Amanda Friedrichs, MD, FAAD AMTA National Conference September 14, 2017

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

Skin Cancer 101: Diagnosis and Management of the Most Common Cancer

The Integumentary System. Mosby items and derived items 2010, 2006, 2002, 1997, 1992 by Mosby, Inc., an affiliate of Elsevier Inc.

General information about skin cancer

SKIN CANCER. Most common cancer diagnosis 40% of all cancers


Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012

Melanoma: The Basics. What is a melanocyte?

Skin and Body Membranes

Learning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating

Skin Cancer - Non-Melanoma

Steven Robinson. Steven Robinson Memorial Endowment at

Malignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry

Skin and Body Membranes Body Membranes Function of body membranes Cover body surfaces Line body cavities Form protective sheets around organs

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

Skin Cancers Emerging Trends and Treatment Approaches

Periocular skin cancer

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 7: Skin Cancer

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am

Healthy Skin Education in Alabama s Schools. Alabama Comprehensive Cancer Control Program

Basal cell carcinoma 5/28/2011

Lid Lesions: Relax or Refer

Oral and Maxillofacial Surgery Department

Epidemiology. Objectives 8/28/2017

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Skin Cancer. Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts Dr Elizabeth Ogden

Technicians & Nurses Program

Premalignant skin tumours

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 13, :30 am 11:00 am

SKIN. 3. How is the skin structured around the finger joints to allow for flexible movement of the fingers?

Skin Care in Renal Transplant Patients

PowerPoint Lecture Slide Presentation by Patty Bostwick-Taylor, Florence-Darlington Technical College Skin and Body Membranes

Integumentary System

Skin Malignancies. Presented by Dr. Douglas Paauw

Work Place Carcinogens Solar Radiation and Skin Cancer. November 2013 Dr Mark Foley

Skin and Body Membranes

MELANOMA. Some people are more likely to get a m Melanoma than others:

Non-melanoma Skin Cancer

Doctors of Optometry Course Notes

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Actinic keratosis (AK): Dr Sarma s simple guide

Disclosures. I have no conflicts of interest to disclose

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

Principles of Anatomy and Physiology

Unit 4 - The Skin and Body Membranes 1

Cancer Reporting for Dermatologists. Florida Department of Health Florida Cancer Data System. March 9, Agenda

They can develop anywhere on the skin and also inside the mouth. They can develop in normal skin or where there is an existing skin mole.

Pathology. Skin Tumor. Bayan N. Mohammad 15/10/2015. Mohammad al-orjani. Page 0 of 23

Regeneron and Sanofi are financial supporters of The Skin Cancer Foundation and collaborated in the development of this article. US-ONC /2018

Actinic Keratoses and Bowen s disease

Disclosures. Melanoma and Non melanoma Skin Cancer: What You Need to Know. I have no conflicts of interest to disclose

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Fluorescence spectroscopy and microscopy of cutaneous tumours correlation between micro- and macro- spectral measurements

NEOPLASMS OF THE SURFACE EPITHELIUM (KERATINOCYTES)

MELANOMA. 4 Fitzroy Square, London W1T 5HQ Tel: Fax: Registered Charity No.

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Sun Safety and Skin Cancer Prevention. Maryland Skin Cancer Prevention Program

Skin cancer pictures scalp

LPN2008 l Volume 4, Number 4

Melanoma. Understanding your diagnosis cancer.ca

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

Cutaneous Adnexal Tumors

Skin Cancer of the Nose: Common and Uncommon

Gross Appearance & Histology of Skin Cancer. Kyle Mannion M.D. January 21, 2005

Finding Melanoma. Is not easy!

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee

Exenteration. Introduction. The skin. Epidermal malignancies 8/3/2017. Neglected basal cell carcinoma

Ch. 4: Skin and Body Membranes

Skin Cancer. All You Need to Keep up to Speed. by Karen L Agnew, Barbara A Gilchrest and Christopher B Bunker. Epidemiology 9.

Diagnostics guidance Published: 11 November 2015 nice.org.uk/guidance/dg19

Skin cancer on the scalp pictures

Describe the functions of the vertebrate integumentary system. Discuss the structure of the skin and how it relates to function.

Transcription:

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY Skin, Bones, and other Private Parts Symposium Dermatology Lectures by Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP

Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP President, National Academy of Dermatology Nurse Practitioners President, American College of Dermatology Nurse Practitioners Owner, Florida Specialty Medical Services, LLC Owner, New Mexico Specialty Medical Services, LLC Owner, National Institute for Dermatology Owner, Dermstaffing No conflicts of interest to report

PART THREE THE SUSPECTS: COMMON CRIMINALS AND DEATH ROW

OBJECTIVES Discuss two risk factors that contribute to skin cancer. Demonstrate understanding of three basic characteristics of describing a lesion. Identify three benign lesions. Identify three skin cancer lesions.

Seborrheic keratoses Sebaceous hyperplasia Xanthelasmas Skin tags Fibrous Papules Dermatofibromas Angioma Solar Lentigenes Venous lake BENIGN LESIONS

MOLE OR NEVUS Most people have a number of small colored spots on their bodies- moles, freckles, birthmarks. The average young adult has at least 25 brown moles. May be present since birth most others develop throughout life. Almost all moles are normal and remain so. a change in a mole or other spot on the skin may be the first sign of an early skin cancer.

ACTINIC KERATOSES (AK) The skin is severely sun damaged and the cells in the outer epidermis layer are now quite abnormal. AKs are scaly or crusty papules or Macules. Aks can also be hypertrophic. If left untreated, they can progress into SCC. Considered precancerous, but some dermatopathologists and dermatologists consider them squamous cell insitu Actinic Cheilitis: More aggressive, solar damage around the lips (vermillion border). Subclinical Aks cannot be seen or felt.

SKIN CANCERS BCC SCC Melanoma

SKIN CANCER FACTS CONT. An estimated 87,110 cases of invasive melanoma in 2017 Estimated 9,730 deaths from melanoma in 2017 (Skin Cancer Foundation, 2017) (American Cancer Society, 2017)

SKIN CANCER FACTS Skin cancer is the most common form of cancer in the United States. More than 5.4 million skin cancers in over 3.3 million people are diagnosed annually Basal cell carcinoma (BCC) is the most common form of skin cancer; an estimated 4 million are diagnosed annually in the US. BCCs are rarely fatal, but can be highly disfiguring if allowed to grow Squamous cell carcinoma (SCC) is the second most common form of skin cancer. An estimated 1 million cases are diagnosed each year in the US. (Skin Cancer Foundation, 2017)

BASAL CELL CARCINOMA Malignant skin tumor Origin basal cell layers cutaneous appendages: skin follicle sebaceous gland eccrine gland apocrine gland Displaying varying clinical appearances or morphology histopathology

BASAL CELL CARCINOMA CONT. Most common malignant tumor Rarely metastasize most are treated effectively Locally destructive leading to disfigurement functional impairment

RISK FACTORS UV Radiation Tanning beds: Studies show that teens are still using tanning beds despite proof of carcinogenic risk Trauma Chemicals Biologic treatment Cancer treatments Genetics

TYPES OF BCC Superficial BCC. These BCCs are the least dangerous. They grow only on the outer layers of the skin. Nodular BCC. These BCCs grow into the deeper layers of the skin. Most of these look like pink round lumps on the skin. Some have an ulcer or crater feature to them. Tough BCC. Infiltrating, micronodular, morphoeic, desmoplastic, sclerosing and morpheaform. Notorious for growing into nearby organs or later recurring nearby. By the time a recurrence is apparent, they may have burrowed into and destroyed other structures. (Australasian College of Skin Cancer Medicine, 2007)

SQUAMOUS CELL CARCINOMA Malignant skin tumor of keratinizing cells of epidermis or its appendages: Hair follicles Sebaceous glands Apocrine glands Eccrine glands

RISK FACTORS Radiation: UV light: sun (tanning); PUVA ionizing radiation Chemical agents: arsenic; hydrocarbons Develop in chronic inflammatory or degenerative conditions: scars; ulcers; sinus tracts Preexisting dermatologic conditions: lichen planus, burns Decreased immunologic competence: HIV Associated with human papillomavirus

TYPES OF SCC In situ SCC. This is the mildest type. The tumor is confined to the outer layer of the skin (epidermis). This type of cancer is also sometimes called Bowen s Disease Well differentiated SCC. This is the commonest type. The SCC has grown into the deeper layers of the skin (dermis). Well differentiated SCCs often appear as very thick crusty lesions on the skin. Often the top falls off. Sometimes patients think they may have gone away. Keratoacanthoma. This is a particular type of SCC that grows very quickly yet is not very dangerous. Often they appear and grow large in 6 to 10 weeks. They can look like a mini volcano. The center of the crater is often full of loose tissue

TYPES OF SCC CONT. Aggressive SCCs. There are several types of SCC in this category. They include poorly differentiated and spindle cell types. These SCCs have a variable appearance of the skin. Some are soft and others are hard. Some bleed on and off. They usually grow quickly and may double in size over months (Australasian College of Skin Cancer Medicine, 2007)

MELANOMA Most serious skin cancer Cancer of the Melanocytes Treatment determined by pathology: -Ulceration, Breslow depth, tumor thickness, mitotic rate -Lymph node involvement -Metastasis

MELANOMA STATISTICS The incidence of melanoma has been steadily increasing for the past 30 years Melanoma is the most common form of cancer for young adults 25-29 years old and the second most common form of cancer for adolescents and young adults 15-29 years old Melanoma is increasing faster in females 15-29 years old than males in the same age group 10,130 deaths annually will be attributed to melanoma

MELANOMA STATISTICS CONT. People with more than 50 moles, atypical moles, or a family history of melanoma are at an increased risk of developing melanoma Less than 1% of skin cancers are melanoma, but causes the vast amount of deaths. The five-year survival rate for people whose melanoma is detected and treated before it spreads to the lymph nodes is 99 percent Five-year survival rates for regional and distant stage melanomas are 62 percent and 18 percent, respectively (Skin Cancer Foundation, 2017)

RISK FACTORS CONT. Fair skin Light Hair and Eye Color Moles - People who have many moles (more than 50) have an increased chance of developing melanoma Dysplastic nevi Personal and family history of melanoma - A previous diagnosis of melanoma increases the risk of getting melanoma again. About 5-10 percent of people with a melanoma will develop it again during their lifetime

RISK FACTORS Non-melanoma skin cancer Weakened immune system Severe sunburns, especially while young Exposure to ultraviolet (UV) radiation, such as sunlight or indoor tanning booths - Exposure to UV radiation is one of the major risk factors for most melanomas. Using tanning beds before age 30 increases your risk of developing melanoma by 75 percent and occasionally using tanning beds can triple your chances. Age - Although melanoma is most common in men over the age of 50 (more common than colon, prostate, and lung cancer), it is also one of the most common cancers in people under the age of 30. Melanoma is the most common form of cancer for young adults 25- to 29-years-old and the second most common cancer in adolescents and young adults 15- to 29-years-old.

TYPES OF MELANOMA Congenital Nevus May be giant or small, and may be present at birth or shortly after birth. May occur anywhere on body -Giant congenital nevus is rare occurring in about 1 of 20,000 births with a lifetime risk of malignant transformation of 2-40%. -Small congenital nevus occurs in 1 of 100 births and lifetime risk of malignant transformation is not known. Lentigo Maligna (Hutchinsons Freckle) Flat pigmented lesion which gradually enlarges, light tan to dark brown or black with irregular notched borders. -Begins as MM in-situ and may take 5 to 50 years to become invasive

TYPES OF MELANOMA CONT. Superficial Spreading Malignant Melanoma Slightly raised lesion with an irregular border and variable, unevenly distributed pigmentation with shades of red, blue, brown, purple, and black Acral Lentiginous Malignant Melanoma Initially the lesion is flat with irregular margins and pigmentation, the lesion rapidly becomes raised and nodular

TYPES OF MELANOMA CONT. Nodular Malignant Melanoma Lesion is raised, nodular and sometimes ulcerated. Borders are irregular and color variegated. Occasionally the tumor has no apparent visible pigmentation (amelanotic MM) (Australasian College of Skin Cancer Medicine, 2007)

QUESTIONS?